Popular Diabetes Drug Ups Phimosis Risk in Men With T2D

Men with T2D who initiate SGLT2 inhibitors vs GLP-1 RAs face an almost twofold elevated risk for phimosis after a year of treatment, a Danish cohort study shows.

who initiated SGLT2 inhibitors showed nearly double the risk for phimosis after 1 year of treatment than those who initiated GLP-1 receptor agonists . This elevated risk persisted for over 8 years of follow-up.

SGLT2 inhibitors decrease hyperglycaemia by promoting glucose excretion through the kidneys, causing glucosuria, but raise concerns about an approximately threefold elevated risk for genital infections.users with T2D who initiated SGLT2 inhibitors and those who initiated GLP-1 RAs from January 2016 to December 2021.penile cancerParticipants were followed up for a median duration of 4 years, with a maximum follow-up duration being 8 years.The use of SGLT2 inhibitors was associated with a nearly twofold higher risk for phimosis than the use of GLP-1 RAs at 1 year . The elevated risk for phimosis with the use of SGLT2 inhibitors vs GLP-1 RAs persisted even after 8 years of follow-up . Although the absolute risk for penile cancer was low, the results suggested that men initiating SGLT2 inhibitors had a higher 8-year cumulative risk for penile cancer than those initiating GLP-1 RAs, corresponding to an RR of 6.34 ."Increased genital infections due to glucosuria in SGLT2i users might therefore contribute to the elevated risks of both phimosis and penile cancer. Of note, any such risk must be weighed against the clear beneficial effects of SGLT2i onThis study was led by Christine Ljungberg, Aarhus University and Aarhus University Hospital, Aarhus, Denmark. It wasDetection bias may have affected the findings as SGLT2 inhibitor users are more likely to develop urogenital symptoms, potentially resulting in more frequent urologic assessments. This study identified few cases of penile cancer, limiting statistical precision for this outcome, and the median follow-up duration of 4 years may have been insufficient for thoroughly assessing the risk for penile cancer. This study lacked information on covariates such as BMI, circumcision status, ethnic diversity, socioeconomic factors, and lifestyle behaviours.This study was supported by Aarhus University. Some authors reported giving presentations and lectures on medical research , receiving research support, teaching healthcare professionals, and having other ties with various pharmaceutical companies. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Diabetes Mellitus Type 2 Diabetes Mellitus Type II Type 2 Diabetes Type 2 DM T2DM T2D Type 2 Diabetes Mellitus (T2DM) Type 2 Diabetes (T2D) UK Site Content United Kingdom Site Content United Kingdom UK Hyperglycemia Phimosis Penile Cancer Cancer Of The Penis SGLT2 Inhibitors Sodium-Glucose Transporter-2 Inhibitors Sodium-Glucose Co-Transporter-2 Inhibitors GLP-1 Receptor Agonists Glucagon-Like Peptide-1 Receptor Agonists CV Risk Cardiovascular Risk CV Risk Factors Cardiovascular Risk Factors Cardiovascular Risk Management Renal Glucosuria Renal Glycosuria Non-Insulin Antidiabetic Drugs Non-Insulin Diabetes Drugs Non-Insulin Anti-Diabetic Drugs Hypoglycemic Agents Antihyperglycemic Agents Hypoglycaemic Agents Antihyperglycaemic Agents

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Paramount+ removes popular all 26 seasons of this popular cartoon amid merger, fight with creatorsIt’s unclear when and if the beloved adult comedy will return to the streaming platform.
Read more »

Oral Semaglutide Offers Kidney Benefits in T2DIn a real-world setting, the administration of oral semaglutide leads to a significant reduction in the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and albuminuria.
Read more »

Early-Onset T2D Rate Doubles in Young Swedish AdultsThe incidence and prevalence of early-onset T2D rose sharply in Sweden from 2006 to 2021, disproportionately affecting young women, individuals with low education, and those born outside Europe.
Read more »

Tirzepatide Outperforms Semaglutide on Combined T2D GoalsTirzepatide outperformed semaglutide in simultaneously achieving four key therapeutic targets for type 2 diabetes.
Read more »

Popular Rogue Fancast, 30, Shoots Down 'X-Men' Casting Rumors [Exclusive]A close-up of a furious, crying Rogue as she flies into danger in X-Men &39;97
Read more »

Poor Sleep Quality May Worsen Emotional Burden in T2DA cross-sectional analysis of a population-based study shows that individuals with type 2 diabetes who experience various forms of sleep impairment report higher levels of diabetes distress.
Read more »